120 related articles for article (PubMed ID: 30621985)
1. E-pharmacophore-based screening of mGluR5 negative allosteric modulators for central nervous system disorder.
Vijaya Prabhu S; Singh SK
Comput Biol Chem; 2019 Feb; 78():414-423. PubMed ID: 30621985
[TBL] [Abstract][Full Text] [Related]
2. Identification of Potential Dual Negative Allosteric Modulators of Group I mGluR Family: A Shape Based Screening, ADME Prediction, Induced Fit Docking and Molecular Dynamics Approach Against Neurodegenerative Diseases.
Prabhu SV; Singh SK
Curr Top Med Chem; 2019; 19(29):2687-2707. PubMed ID: 31702505
[TBL] [Abstract][Full Text] [Related]
3. Atom-based 3D-QSAR, induced fit docking, and molecular dynamics simulations study of thieno[2,3-b]pyridines negative allosteric modulators of mGluR5.
Vijaya Prabhu S; Singh SK
J Recept Signal Transduct Res; 2018 Jun; 38(3):225-239. PubMed ID: 29806525
[TBL] [Abstract][Full Text] [Related]
4. Energetically optimized pharmacophore modeling to identify dual negative allosteric modulators against group I mGluRs in neurodegenerative diseases.
Prabhu SV; Singh SK
J Biomol Struct Dyn; 2020 May; 38(8):2326-2337. PubMed ID: 31392928
[TBL] [Abstract][Full Text] [Related]
5. Interaction of novel positive allosteric modulators of metabotropic glutamate receptor 5 with the negative allosteric antagonist site is required for potentiation of receptor responses.
Chen Y; Nong Y; Goudet C; Hemstapat K; de Paulis T; Pin JP; Conn PJ
Mol Pharmacol; 2007 May; 71(5):1389-98. PubMed ID: 17303702
[TBL] [Abstract][Full Text] [Related]
6. Neurophysiological signals as potential translatable biomarkers for modulation of metabotropic glutamate 5 receptors.
Harvey BD; Siok CJ; Kiss T; Volfson D; Grimwood S; Shaffer CL; Hajós M
Neuropharmacology; 2013 Dec; 75():19-30. PubMed ID: 23831682
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and optimization of 4,5,6,7-tetrahydrooxazolo[4,5-c]pyridines as potent and orally-active metabotropic glutamate receptor 5 negative allosteric modulators.
Hirose W; Kato Y; Natsutani I; Takata M; Kitaichi M; Imai S; Hayashi S; Arai Y; Hoshino K; Yoshida K
Bioorg Med Chem Lett; 2017 Sep; 27(18):4331-4335. PubMed ID: 28838696
[TBL] [Abstract][Full Text] [Related]
8. Insights into the interaction of negative allosteric modulators with the metabotropic glutamate receptor 5: discovery and computational modeling of a new series of ligands with nanomolar affinity.
Anighoro A; Graziani D; Bettinelli I; Cilia A; De Toma C; Longhi M; Mangiarotti F; Menegon S; Pirona L; Poggesi E; Riva C; Rastelli G
Bioorg Med Chem; 2015 Jul; 23(13):3040-58. PubMed ID: 26014480
[TBL] [Abstract][Full Text] [Related]
9. 7TM X-ray structures for class C GPCRs as new drug-discovery tools. 1. mGluR5.
Topiol S; Sabio M
Bioorg Med Chem Lett; 2016 Jan; 26(2):484-494. PubMed ID: 26706173
[TBL] [Abstract][Full Text] [Related]
10. Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu5 Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile).
Christopher JA; Aves SJ; Bennett KA; Doré AS; Errey JC; Jazayeri A; Marshall FH; Okrasa K; Serrano-Vega MJ; Tehan BG; Wiggin GR; Congreve M
J Med Chem; 2015 Aug; 58(16):6653-64. PubMed ID: 26225459
[TBL] [Abstract][Full Text] [Related]
11. Profiling the Structural Determinants of Aryl Benzamide Derivatives as Negative Allosteric Modulators of mGluR5 by In Silico Study.
Zhao Y; Chen J; Liu Q; Li Y
Molecules; 2020 Jan; 25(2):. PubMed ID: 31963723
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Binding Mechanism of Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators in Clinical Trials by Molecular Dynamics Simulations.
Fu T; Zheng G; Tu G; Yang F; Chen Y; Yao X; Li X; Xue W; Zhu F
ACS Chem Neurosci; 2018 Jun; 9(6):1492-1502. PubMed ID: 29522307
[TBL] [Abstract][Full Text] [Related]
13. Thieno[2,3-b]pyridines as negative allosteric modulators of metabotropic GluR5 receptors: hit-to-lead optimization.
Nógrádi K; Wágner G; Domány G; Bobok A; Magdó I; Kiss B; Kolok S; Fónagy K; Gyertyán I; Háda V; Kóti J; Gál K; Farkas S; Keserű GM; Greiner I; Szombathelyi Z
Bioorg Med Chem Lett; 2014 Aug; 24(16):3845-9. PubMed ID: 25017030
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 6-(pyrimidin-5-ylmethyl)quinoline-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5.
Felts AS; Rodriguez AL; Morrison RD; Blobaum AL; Byers FW; Daniels JS; Niswender CM; Conn PJ; Lindsley CW; Emmitte KA
Bioorg Med Chem Lett; 2018 Jun; 28(10):1679-1685. PubMed ID: 29705142
[TBL] [Abstract][Full Text] [Related]
15. Metabotropic glutamate receptor 5 negative allosteric modulators: discovery of 2-chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]pyridine (basimglurant, RO4917523), a promising novel medicine for psychiatric diseases.
Jaeschke G; Kolczewski S; Spooren W; Vieira E; Bitter-Stoll N; Boissin P; Borroni E; Büttelmann B; Ceccarelli S; Clemann N; David B; Funk C; Guba W; Harrison A; Hartung T; Honer M; Huwyler J; Kuratli M; Niederhauser U; Pähler A; Peters JU; Petersen A; Prinssen E; Ricci A; Rueher D; Rueher M; Schneider M; Spurr P; Stoll T; Tännler D; Wichmann J; Porter RH; Wettstein JG; Lindemann L
J Med Chem; 2015 Feb; 58(3):1358-71. PubMed ID: 25565255
[TBL] [Abstract][Full Text] [Related]
16. Discovery and Preclinical Characterization of 3-((4-(4-Chlorophenyl)-7-fluoroquinoline-3-yl)sulfonyl)benzonitrile, a Novel Non-acetylenic Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric Modulator for Psychiatric Indications.
Galambos J; Bielik A; Krasavin M; Orgován Z; Domány G; Nógrádi K; Wágner G; Balogh GT; Béni Z; Kóti J; Szakács Z; Bobok A; Kolok S; Mikó-Bakk ML; Vastag M; Sághy K; Laszy J; Halász AS; Balázs O; Gál K; Greiner I; Szombathelyi Z; Keserű GM
J Med Chem; 2017 Mar; 60(6):2470-2484. PubMed ID: 28212015
[TBL] [Abstract][Full Text] [Related]
17. A close structural analog of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators.
Rodriguez AL; Nong Y; Sekaran NK; Alagille D; Tamagnan GD; Conn PJ
Mol Pharmacol; 2005 Dec; 68(6):1793-802. PubMed ID: 16155210
[TBL] [Abstract][Full Text] [Related]
18. Allosteric Modulation Mechanism of the mGluR
Cong X; Chéron JB; Golebiowski J; Antonczak S; Fiorucci S
J Chem Inf Model; 2019 Jun; 59(6):2871-2878. PubMed ID: 31025859
[TBL] [Abstract][Full Text] [Related]
19. Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression.
Hughes ZA; Neal SJ; Smith DL; Sukoff Rizzo SJ; Pulicicchio CM; Lotarski S; Lu S; Dwyer JM; Brennan J; Olsen M; Bender CN; Kouranova E; Andree TH; Harrison JE; Whiteside GT; Springer D; O'Neil SV; Leonard SK; Schechter LE; Dunlop J; Rosenzweig-Lipson S; Ring RH
Neuropharmacology; 2013 Mar; 66():202-14. PubMed ID: 22551786
[TBL] [Abstract][Full Text] [Related]
20. Difluorocyclobutylacetylenes as positive allosteric modulators of mGluR5 with reduced bioactivation potential.
Degnan AP; Maxwell D; Balakrishnan A; Brown JM; Easton A; Gulianello M; Hanumegowda U; Hill-Drzewi M; Miller R; Santone KS; Senapati A; Shields EE; Sivarao DV; Westphal R; Whiterock VJ; Zhuo X; Bronson JJ; Macor JE
Bioorg Med Chem Lett; 2016 Dec; 26(24):5871-5876. PubMed ID: 27856084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
